Cliff Asness's HRMY Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 716,246 shares of Harmony Biosciences Holdings, Inc. (HRMY) worth $20.06 M, representing 0.01% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in HRMY, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 458,321 shares. Largest reduction occurred in Q1 2026, reducing 97,643 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Harmony Biosciences Holdings (HRMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Harmony Biosciences Holdings (HRMY) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -97,643 | Reduce 12.00% | 716,246 | $28.01 |
| Q4 2025 | +458,321 | Add 128.90% | 813,889 | $37.42 |
| Q3 2025 | +203,539 | Add 133.88% | 355,568 | $27.56 |
| Q2 2025 | -14,311 | Reduce 8.60% | 152,029 | $31.60 |
| Q1 2025 | +7,484 | Add 4.71% | 166,340 | $33.19 |
| Q4 2024 | +16,271 | Add 11.41% | 158,856 | $34.41 |
| Q3 2024 | -11,760 | Reduce 7.62% | 142,585 | $40.00 |
| Q2 2024 | +1,116 | Add 0.73% | 154,345 | $30.17 |
| Q1 2024 | -26,526 | Reduce 14.76% | 153,229 | $33.58 |
| Q4 2023 | +11,236 | Add 6.67% | 179,755 | $32.30 |
| Q3 2023 | +22,126 | Add 15.11% | 168,519 | $32.77 |
| Q2 2023 | +92,843 | Add 173.38% | 146,393 | $35.19 |
| Q1 2023 | +21,627 | Add 67.75% | 53,550 | $32.65 |
| Q4 2022 | -1,453 | Reduce 4.35% | 31,923 | $55.10 |
| Q3 2022 | +22,653 | Add 211.26% | 33,376 | $44.28 |
| Q2 2022 | +10,723 | New Buy | 10,723 | $48.77 |
Cliff Asness's Harmony Biosciences Holdings Investment FAQs
Cliff Asness first purchased Harmony Biosciences Holdings, Inc. (HRMY) in Q2 2022, acquiring 10,723 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Harmony Biosciences Holdings, Inc. (HRMY) for 16 quarters since Q2 2022.
Cliff Asness's largest addition to Harmony Biosciences Holdings, Inc. (HRMY) was in Q4 2025, adding 813,889 shares worth $30.46 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 716,246 shares of Harmony Biosciences Holdings, Inc. (HRMY), valued at approximately $20.06 M.
As of the Q1 2026 filing, Harmony Biosciences Holdings, Inc. (HRMY) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Harmony Biosciences Holdings, Inc. (HRMY) was 813,889 shares, as reported at the end of Q4 2025.